Acetaminophen protects hippocampal neurons and PC12 cultures from amyloid β-peptides induced oxidative stress and reduces NF-κB activation

Neurochemistry International

Volumn 41, Issue 1, 2002, Pages 43-54

  Bisaglia, M ^a,b   Venezia, V ^a,b   Piccioli, P ^a   Stanzione, S ^a   Porcile, C ^a   Russo, C ^a,b   Mancini, F ^c   Milanese, C ^c   Schettini, G ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Università Politecnica delle Marche ACRAF Gruppo Angelini   (Italy)

Author keywords

Acetaminophen; Amyloid; Neuronal cultures; NF B; Oxidative stress

Indexed keywords

AMYLOID BETA PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN MITOCHONDRION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; HIPPOCAMPUS; LIPID PEROXIDATION; NERVE CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ACETAMINOPHEN; AMYLOID BETA-PROTEIN; ANIMALS; APOPTOSIS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HIPPOCAMPUS; NEURONS; NF-KAPPA B; OXIDATIVE STRESS; PC12 CELLS; PEPTIDE FRAGMENTS; RATS;

EID: 0036208563     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(01)00136-X     Document Type: Article

References (73)

1. The mechanisms of action of nonsteroidal antiinflammatory drugs
2. Thrombin activates nuclear factor-κB and potentiates endothelial cell activation by TNF
3. Vitamin E protects nerve cells from amyloid beta protein toxicity
4. Hydrogen peroxide mediates amyloid beta protein toxicity
5. C3-fullero-tris-methanodicarboxylic acid protects cerebellar granule cells from apoptosis
6. Interaction of indomethacin with cytokine production in whole blood. Potential mechanism for a brain-protective effect
7. Survival and growth of hippocampal neurons in defined medium at low density: Advantages of a sandwich culture technique or low oxygen
8. Methodological variables in the assessment of beta amyloid neurotoxicity
9. Elevated oxidative stress in models of normal brain aging and Alzheimer's disease
10. β-amyloid of Alzheimer's disease induces reactive gliosis that inhibits axonal outgrowth
11. Effects of apolipoprotein E (apoE) isoforms, β-amyloid (Abeta) and apoE/Abeta complexes on protein kinase C-alpha (PKC-alpha) translocation and amyloid precursor protein (APP) processing in human SH-SY5Y neuroblastoma cells and fibroblasts
12. Protection from oxidation enhances the survival of cultured mesencephalic neurons
13. What the evolution of the amyloid protein precursor supergene family tells us about its function
14. Sodium salicylate and 17β-estradiol attenuate nuclear transcription factor NF-κB translocation in cultured rat astroglial cultures following exposure to amyloid A β(1-40) and lipopolysaccharides
15. Prospects for pharmacological intervention in Alzheimer disease
16. The role of complement in Alzheimer's disease pathology
17. Aggregated amyloid-beta protein induces cortical neuronal apoptosis and concomitant apoptotic pattern of gene induction
18. Pharmacologic management of Alzheimer disease part III: Nonsteroidal antiinflammatory drugs - Emerging protective evidence
19. Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35
20. 2+ influx
21. Rapid changes in the distribution of GAP-43 correlate with the expression of neuronal polarity during normal development and under experimental conditions
22. Interleukin-1 expression in different plaque types in Alzheimer's disease: Significance in plaque evolution
23. Neuroportection by aspirin and sodium salicilate through blockade of NF-κB activation
24. Secreted β-amyloid precursor protein counteracts the proapoptotic action of mutant presenilin-1 by activation of NF-κB and stabilization of calcium homeostasis
25. Amyloid, the presenilins and Alzheimer's disease
26. Human platelet calcium mobilisation in response to β-amyloid (25-35): Buffer dependency and unchanged response in Alzheimer's disease
27. Mitochondrial abnormalities in Alzheimer's disease
28. Anti-inflammatory drugs: A hope for Alzheimer's disease
29. Causes of Alzheimer's disease: Paracetamol (acetaminophen) today? Amphetamines tomorrow
30. Constitutive NF-κB activity in neurons
31. Transcription factor NF-κB is activated in microglia during experimental autoimmune encephalomyelitis
32. Transcription factor NF-κB is activated in primary neurons by amyloid β peptides and in neurons surrounding early plaques from patients with Alzheimer disease
33. Brain cytochrome oxidase in Alzheimer's disease
34. Inflammatory molecule release by β-amyloid-treated T98G astrocytoma cells: Role of prostaglandins and modulation by paracetamol
35. Apoptosis is induced by β-amyloid in cultured central nervous system neurons
36. 2+ homeostasis and cell death
37. Oxidative stress hypothesis in Alzheimer's disease
38. Oxidative alterations in Alzheimer's disease
39. Constraints on prostaglandin biosynthesis in tissues
40. Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium
41. β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity
42. 2+ homeostasis in Alzheimer's disease
43. Cyclo-oxygenase-2 inhibitors: Rationale and therapeutic potential for Alzheimer's disease
44. Inflammation of the brain in Alzheimer's disease: Implications for therapy
45. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies
46. NF-κB as a primary regulator of the stress response
47. Glial cytokines in Alzheimer's disease: Review and pathogenic implications
48. Cortical cytochrome oxidase activity is reduced in Alzheimer's disease
49. Inhibition of inducible nitric oxide synthase gene expression by indomethacin or ibuprofen in β-amyloid protein-stimulated J774 cells
50. Cytochrome c oxidase in Alzheimer's disease brain: Purification and characterization
51. Mitochondrial function impairment induced by amyloid β-peptide in PC12 cells
52. Mitochondria and programmed cell death: Back to the future
53. β-amyloid induces neuritic dystrophy in vitro: Similarities with Alzheimer pathology
54. Structure-activity analyses of β-amyloid peptides: Contributions of the beta 25-35 region to aggregation and neurotoxicity
55. β-amyloid neurotoxicity in vitro: Evidence of oxidative stress but not protection by antioxidants
56. Investigation of mechanisms of acetaminophen toxicity in isolated rat hepatocytes with the acetaminophen analogues 3,5-dimethylacetaminophen and 2,6-dimethylacetaminophen
57. Heterogeneity of water-soluble amyloid beta-peptide in Alzheimer's disease and Down's syndrome brains
58. Dominant and differential deposition of distinct β-amyloid peptide species, A beta N3(pE), in senile plaques
59. Amino- and carboxy-terminal heterogeneity of β-amyloid peptides deposited in human brain
60. Beta 25-35 alters calcium homeostasis and induces neurotoxicity in cerebellar granule cells
61. Amyloid beta-protein and the genetics of Alzheimer's disease
62. Evidence for apoptotic cell death in Alzheimer's disease
63. Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress
64. Risk of Alzheimer's disease and duration of NSAID use
65. Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients
66. Immunohistochemical evidence for apoptosis in Alzheimer's disease
67. N-terrminal heterogeneity of parenchymal and cerebrovascular Abeta deposits
68. Toxicity of pyroglutaminated amyloid β-peptides 3(pE)-40 and -42 is similar to that of Aβ1-40 and -42
69. Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger
70. Accumulation of intercellular adhesion molecule-1 in senile plaques in brain tissue of patients with Alzheimer's disease
71. Huperzine B, a novel acetylcholinesterase inhibitor, attenuates hydrogen peroxide induced injury in PC12 cell
72. 2 generation